Biotech Values

[DewDiligence]

Big Pharma Market Caps

If one counts AMGN and DNA as “Big Pharma,” the number of
Big Pharma will soon shrink by 20% from 15 companies to 12
companies. The 12 survivors* in descending order of pro-forma
market cap are:

 
            Pro Forma 
          Market Cap ($B) 
 Roche/DNA     153 
 PFE/WYE       144 
 JNJ           132 
 MRK/SGP        87 
 NVS            77 
 GSK            71 
 ABT            69 
 SNY            66 
 AMGN           49 
 AZN            45 
 BMY            39 
 LLY            32

*GILD and TEVA have market caps large enough to be
in this table, but I do not consider them “Big Pharma.”